HOB Biotech Group Corp Ltd (688656) — Working Capital to Net Assets Ratio
HOB Biotech Group Corp Ltd (688656) has a Working Capital to Net Assets ratio of 17.5% as of March 2026. Working capital of CN¥144.91 Million (current assets of CN¥227.57 Million minus current liabilities of CN¥82.65 Million) is measured against net assets of CN¥826.70 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688656 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
HOB Biotech Group Corp Ltd Working Capital to Net Assets (2016–2025)
This chart shows how HOB Biotech Group Corp Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 17.5%, reflecting working capital of CN¥144.91 Million against net assets of CN¥826.70 Million CNY. See 688656 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for HOB Biotech Group Corp Ltd (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for HOB Biotech Group Corp Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see HOB Biotech Group Corp Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 15.5% | CN¥127.26 Million | CN¥820.01 Million | CN¥235.79 Million | CN¥108.54 Million | ▲ +5.4 pp |
| 2024 | 10.1% | CN¥82.18 Million | CN¥812.14 Million | CN¥292.12 Million | CN¥209.94 Million | ▼ -13.6 pp |
| 2023 | 23.7% | CN¥192.46 Million | CN¥810.73 Million | CN¥328.21 Million | CN¥135.75 Million | ▼ -10.9 pp |
| 2022 | 34.7% | CN¥270.27 Million | CN¥779.57 Million | CN¥422.98 Million | CN¥152.72 Million | ▼ -28.2 pp |
| 2021 | 62.8% | CN¥483.80 Million | CN¥770.00 Million | CN¥569.97 Million | CN¥86.17 Million | ▲ +16.6 pp |
| 2020 | 46.2% | CN¥95.43 Million | CN¥206.39 Million | CN¥158.65 Million | CN¥63.23 Million | ▲ +10.4 pp |
| 2019 | 35.8% | CN¥53.60 Million | CN¥149.64 Million | CN¥176.49 Million | CN¥122.89 Million | ▼ -11.3 pp |
| 2018 | 47.2% | CN¥62.78 Million | CN¥133.12 Million | CN¥140.38 Million | CN¥77.60 Million | ▲ +27.3 pp |
| 2017 | 19.9% | CN¥15.69 Million | CN¥79.03 Million | CN¥68.69 Million | CN¥53.00 Million | ▲ +23.4 pp |
| 2016 | -3.6% | CN¥-2.03 Million | CN¥56.71 Million | CN¥52.73 Million | CN¥54.76 Million | — |